Share Price and Basic Stock Data
Last Updated: October 14, 2025, 9:29 pm
PEG Ratio | 8.93 |
---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Mohini Health & Hygiene Ltd operates in the Medical Equipment & Accessories sector, with a current share price of ₹50.0 and a market capitalization of ₹91.1 Cr. Over the past several years, the company’s revenue has shown a fluctuating trend, with total sales reported at ₹127 Cr in FY 2019, rising to ₹192 Cr in FY 2023. The sales figures for the latest half-yearly report stood at ₹101 Cr for Sep 2023, reflecting a continued upward trajectory. However, forecasts for upcoming quarters indicate a decline, with ₹76 Cr projected for Mar 2025. The company’s operating profit margin (OPM) has been inconsistent, recorded at 3% recently. This suggests that while sales have increased, cost management remains a critical area for improvement. The cash conversion cycle (CCC) of 127 days indicates that the company takes a considerable time to convert its investments in inventory and accounts receivable into cash. Overall, while revenue growth is evident, the challenges in maintaining profitability and cash flow efficiency are significant hurdles to be addressed.
Profitability and Efficiency Metrics
Profitability at Mohini Health & Hygiene Ltd has exhibited variability, with net profit recorded at ₹6 Cr for FY 2024, a slight increase from ₹5 Cr in FY 2023. The earnings per share (EPS) for Mar 2024 stood at ₹3.07, showing a gradual recovery from previous periods. The company’s return on equity (ROE) is reported at 10%, while the return on capital employed (ROCE) is higher at 14.1%, indicating effective use of capital in generating returns. However, the OPM of 3% reflects challenges in managing operational costs effectively. The interest coverage ratio (ICR) is a healthy 5.16x, suggesting that the company can comfortably meet its interest obligations. Despite these strengths, the net profit margin has remained lower than industry averages, indicating room for improvement in operational efficiency. The combination of fluctuating margins and profitability metrics highlights the need for strategic initiatives to enhance operational performance and cost management.
Balance Sheet Strength and Financial Ratios
The balance sheet of Mohini Health & Hygiene Ltd reveals a mix of strengths and weaknesses. The total borrowings stand at ₹35 Cr against reserves of ₹87 Cr, yielding a debt-to-equity ratio of 0.22, indicating a relatively low reliance on debt financing. This is further supported by a current ratio of 3.19, suggesting robust liquidity and an ability to cover short-term liabilities. However, the company’s asset turnover ratio is reported at 1.44, which is acceptable but indicates that there may be inefficiencies in utilizing assets to generate sales. The price-to-book value (P/BV) ratio is at 0.95x, which is close to the industry average, indicating that the stock might be fairly valued compared to its net assets. Overall, while the balance sheet reflects a strong capital base, the efficiency ratios suggest that operational improvements are necessary to maximize asset utilization and enhance profitability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Mohini Health & Hygiene Ltd indicates a strong promoter presence, holding 64.02% of the shares, which reflects significant insider confidence in the company’s direction. The public holds 34.96%, while foreign institutional investors (FIIs) and domestic institutional investors (DIIs) have negligible stakes at 0%. The total number of shareholders has slightly decreased to 737 from previous periods, which may suggest waning investor interest or consolidation among shareholders. The absence of institutional investment could be a risk factor, as it may reflect a lack of broader market confidence. However, the high promoter stake can also be seen as a stabilizing factor, potentially leading to strategic decisions that align with long-term growth. This shareholder composition may impact liquidity and the stock’s performance, particularly in volatile market conditions.
Outlook, Risks, and Final Insight
If margins sustain at current levels, Mohini Health & Hygiene Ltd could see a gradual improvement in profitability, driven by increased operational efficiency and cost management initiatives. However, the company faces risks, including fluctuating sales trends and a lengthy cash conversion cycle, which could hinder liquidity. The reliance on a single sector may also expose it to market volatility and changes in healthcare demand. Conversely, a strong promoter stake may provide stability and foster strategic growth initiatives. If the company can effectively manage its expenses and improve operational efficiencies, it may enhance its profitability and attract institutional investors, thereby boosting market confidence. Overall, while challenges persist, the potential for recovery and growth remains contingent on strategic operational improvements and market conditions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Mohini Health & Hygiene Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Constronics Infra Ltd | 78.9 Cr. | 63.0 | 158/46.0 | 18.8 | 30.9 | 0.00 % | 19.7 % | 15.8 % | 10.0 |
Centenial Surgical Suture Ltd | 37.2 Cr. | 102 | 189/82.2 | 84.3 | 0.00 % | 3.94 % | 4.64 % | 10.0 | |
Adeshwar Meditex Ltd | 31.4 Cr. | 21.8 | 26.5/15.0 | 15.8 | 25.6 | 0.00 % | 8.27 % | 5.51 % | 10.0 |
Poly Medicure Ltd | 19,460 Cr. | 1,920 | 3,358/1,821 | 54.4 | 273 | 0.18 % | 20.1 % | 15.8 % | 5.00 |
Mohini Health & Hygiene Ltd | 93.6 Cr. | 51.3 | 86.9/46.0 | 9.06 | 57.8 | 0.00 % | 14.1 % | 10.0 % | 10.0 |
Industry Average | 19,460.00 Cr | 431.62 | 24.52 | 94.32 | 0.04% | 13.22% | 10.35% | 9.00 |
Quarterly Result
Metric | Mar 2019 | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 59 | 62 | 66 | 72 | 63 | 46 | 82 | 99 | 93 | 101 | 98 | 91 | 76 |
Expenses | 48 | 54 | 63 | 60 | 59 | 40 | 78 | 94 | 85 | 94 | 92 | 82 | 74 |
Operating Profit | 10 | 8 | 3 | 12 | 5 | 6 | 4 | 5 | 7 | 8 | 6 | 9 | 3 |
OPM % | 18% | 13% | 4% | 17% | 7% | 13% | 4% | 5% | 8% | 8% | 6% | 10% | 3% |
Other Income | 0 | 0 | 6 | 0 | 0 | 1 | 6 | 6 | 0 | 4 | 4 | 1 | 3 |
Interest | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 3 | 2 | 2 | 1 | 2 |
Depreciation | 3 | 2 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 3 |
Profit before tax | 5 | 4 | 4 | 7 | 0 | 2 | 6 | 8 | 3 | 7 | 6 | 7 | 2 |
Tax % | 0% | 5% | 31% | 0% | 3,780% | 25% | 31% | 32% | 46% | 28% | 10% | 30% | 35% |
Net Profit | 5 | 4 | 3 | 7 | -2 | 2 | 4 | 5 | 2 | 5 | 6 | 5 | 1 |
EPS in Rs | 2.74 | 1.99 | 1.48 | 4.10 | -1.01 | 0.90 | 2.09 | 2.81 | 0.91 | 2.83 | 3.07 | 2.64 | 0.61 |
Last Updated: May 31, 2025, 8:24 am
Below is a detailed analysis of the quarterly data for Mohini Health & Hygiene Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 76.00 Cr.. The value appears to be declining and may need further review. It has decreased from 91.00 Cr. (Sep 2024) to 76.00 Cr., marking a decrease of 15.00 Cr..
- For Expenses, as of Mar 2025, the value is 74.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 82.00 Cr. (Sep 2024) to 74.00 Cr., marking a decrease of 8.00 Cr..
- For Operating Profit, as of Mar 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Sep 2024) to 3.00 Cr., marking a decrease of 6.00 Cr..
- For OPM %, as of Mar 2025, the value is 3.00%. The value appears to be declining and may need further review. It has decreased from 10.00% (Sep 2024) to 3.00%, marking a decrease of 7.00%.
- For Other Income, as of Mar 2025, the value is 3.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Sep 2024) to 3.00 Cr., marking an increase of 2.00 Cr..
- For Interest, as of Mar 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Sep 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Mar 2025, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Sep 2024) to 3.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Mar 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Sep 2024) to 2.00 Cr., marking a decrease of 5.00 Cr..
- For Tax %, as of Mar 2025, the value is 35.00%. The value appears to be increasing, which may not be favorable. It has increased from 30.00% (Sep 2024) to 35.00%, marking an increase of 5.00%.
- For Net Profit, as of Mar 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Sep 2024) to 1.00 Cr., marking a decrease of 4.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is 0.61. The value appears to be declining and may need further review. It has decreased from 2.64 (Sep 2024) to 0.61, marking a decrease of 2.03.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:50 am
Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 49 | 91 | 122 | 137 | 148 | 127 | 128 | 135 | 127 | 192 | 200 | 168 |
Expenses | 47 | 86 | 112 | 127 | 130 | 107 | 117 | 118 | 118 | 179 | 186 | 155 |
Operating Profit | 2 | 5 | 10 | 10 | 17 | 20 | 11 | 17 | 9 | 13 | 14 | 12 |
OPM % | 4% | 5% | 8% | 7% | 12% | 16% | 8% | 12% | 7% | 7% | 7% | 7% |
Other Income | 0 | 0 | 1 | 3 | 2 | 1 | 6 | 0 | 7 | 6 | 8 | 4 |
Interest | 1 | 1 | 4 | 3 | 7 | 5 | 4 | 4 | 4 | 4 | 4 | 3 |
Depreciation | 0 | 1 | 3 | 3 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 5 |
Profit before tax | 1 | 3 | 4 | 8 | 7 | 10 | 8 | 8 | 8 | 11 | 13 | 9 |
Tax % | 32% | 24% | 10% | 27% | 30% | 26% | 18% | 25% | 29% | 36% | 20% | 31% |
Net Profit | 1 | 2 | 4 | 6 | 5 | 8 | 6 | 6 | 5 | 7 | 11 | 6 |
EPS in Rs | 2.88 | 7.62 | 15.03 | 18.83 | 2.81 | 4.21 | 3.46 | 3.09 | 2.99 | 3.72 | 5.89 | 3.25 |
Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | 8% | 15% |
YoY Net Profit Growth
Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 100.00% | 100.00% | 50.00% | -16.67% | 60.00% | -25.00% | 0.00% | -16.67% | 40.00% | 57.14% | -45.45% |
Change in YoY Net Profit Growth (%) | 0.00% | 0.00% | -50.00% | -66.67% | 76.67% | -85.00% | 25.00% | -16.67% | 56.67% | 17.14% | -102.60% |
Mohini Health & Hygiene Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
No data available for the compounded sales growth chart.
Balance Sheet
Last Updated: June 16, 2025, 11:41 am
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3 | 3 | 3 | 3 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
Reserves | 10 | 12 | 16 | 21 | 40 | 48 | 54 | 59 | 65 | 71 | 82 | 87 |
Borrowings | 23 | 52 | 58 | 65 | 56 | 51 | 42 | 43 | 44 | 28 | 23 | 35 |
Other Liabilities | 5 | 18 | 11 | 18 | 20 | 16 | 19 | 22 | 22 | 21 | 17 | 28 |
Total Liabilities | 40 | 84 | 87 | 107 | 133 | 133 | 133 | 143 | 148 | 138 | 140 | 168 |
Fixed Assets | 6 | 44 | 42 | 41 | 64 | 63 | 60 | 64 | 50 | 49 | 40 | 37 |
CWIP | 18 | 0 | 1 | 21 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
Other Assets | 17 | 40 | 44 | 44 | 70 | 70 | 72 | 79 | 98 | 89 | 98 | 127 |
Total Assets | 40 | 84 | 87 | 107 | 133 | 133 | 133 | 143 | 148 | 138 | 140 | 168 |
Below is a detailed analysis of the balance sheet data for Mohini Health & Hygiene Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 18.00 Cr..
- For Reserves, as of Mar 2025, the value is 87.00 Cr.. The value appears strong and on an upward trend. It has increased from 82.00 Cr. (Mar 2024) to 87.00 Cr., marking an increase of 5.00 Cr..
- For Borrowings, as of Mar 2025, the value is 35.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 23.00 Cr. (Mar 2024) to 35.00 Cr., marking an increase of 12.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 28.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 17.00 Cr. (Mar 2024) to 28.00 Cr., marking an increase of 11.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 168.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 140.00 Cr. (Mar 2024) to 168.00 Cr., marking an increase of 28.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 40.00 Cr. (Mar 2024) to 37.00 Cr., marking a decrease of 3.00 Cr..
- For CWIP, as of Mar 2025, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
- For Other Assets, as of Mar 2025, the value is 127.00 Cr.. The value appears strong and on an upward trend. It has increased from 98.00 Cr. (Mar 2024) to 127.00 Cr., marking an increase of 29.00 Cr..
- For Total Assets, as of Mar 2025, the value is 168.00 Cr.. The value appears strong and on an upward trend. It has increased from 140.00 Cr. (Mar 2024) to 168.00 Cr., marking an increase of 28.00 Cr..
Notably, the Reserves (87.00 Cr.) exceed the Borrowings (35.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | -21.00 | -47.00 | -48.00 | -55.00 | -39.00 | -31.00 | -31.00 | -26.00 | -35.00 | -15.00 | -9.00 | -23.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 26 | 133 | 49 | 64 | 89 | 82 | 65 | 60 | 112 | 67 | 72 | 39 |
Inventory Days | 52 | 15 | 58 | 37 | 44 | 79 | 94 | 126 | 106 | 65 | 55 | 117 |
Days Payable | 13 | 44 | 14 | 13 | 15 | 16 | 28 | 25 | 18 | 16 | 10 | 29 |
Cash Conversion Cycle | 65 | 105 | 93 | 88 | 117 | 145 | 131 | 161 | 200 | 116 | 117 | 127 |
Working Capital Days | 72 | 43 | 24 | 1 | 47 | 66 | 70 | 66 | 110 | 96 | 116 | 120 |
ROCE % | 8% | 6% | 12% | 13% | 14% | 14% | 10% | 10% | 9% | 12% | 14% | 14% |
This stock is not held by any mutual fund.
Key Financial Ratios
Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 3.21 | 5.86 | 3.72 | 3.71 | 3.25 |
Diluted EPS (Rs.) | 3.21 | 5.86 | 3.72 | 3.71 | 3.25 |
Cash EPS (Rs.) | 5.83 | 8.22 | 6.07 | 6.78 | 6.39 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 57.76 | 55.05 | 49.19 | 46.03 | 42.70 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 57.76 | 55.05 | 49.19 | 46.03 | 42.70 |
Revenue From Operations / Share (Rs.) | 92.00 | 109.46 | 105.29 | 77.94 | 75.39 |
PBDIT / Share (Rs.) | 12.50 | 12.00 | 10.44 | 9.59 | 9.90 |
PBIT / Share (Rs.) | 9.88 | 9.64 | 8.10 | 6.69 | 6.90 |
PBT / Share (Rs.) | 8.15 | 7.31 | 5.82 | 4.77 | 4.54 |
Net Profit / Share (Rs.) | 3.21 | 5.86 | 3.72 | 3.89 | 3.39 |
NP After MI And SOA / Share (Rs.) | 3.21 | 5.86 | 3.72 | 3.71 | 3.25 |
PBDIT Margin (%) | 13.58 | 10.96 | 9.91 | 12.30 | 13.13 |
PBIT Margin (%) | 10.74 | 8.80 | 7.69 | 8.58 | 9.14 |
PBT Margin (%) | 8.85 | 6.68 | 5.53 | 6.12 | 6.02 |
Net Profit Margin (%) | 3.48 | 5.35 | 3.53 | 4.98 | 4.49 |
NP After MI And SOA Margin (%) | 3.48 | 5.35 | 3.53 | 4.76 | 4.30 |
Return on Networth / Equity (%) | 5.55 | 10.64 | 7.56 | 8.12 | 7.63 |
Return on Capital Employeed (%) | 16.10 | 15.83 | 14.35 | 13.05 | 13.42 |
Return On Assets (%) | 3.48 | 7.65 | 4.90 | 4.30 | 4.03 |
Long Term Debt / Equity (X) | 0.01 | 0.05 | 0.09 | 0.06 | 0.15 |
Total Debt / Equity (X) | 0.32 | 0.22 | 0.31 | 0.52 | 0.46 |
Asset Turnover Ratio (%) | 1.09 | 1.44 | 1.30 | 0.93 | 0.98 |
Current Ratio (X) | 2.08 | 3.19 | 2.43 | 1.57 | 1.47 |
Quick Ratio (X) | 1.42 | 2.41 | 1.73 | 1.15 | 0.89 |
Inventory Turnover Ratio (X) | 4.38 | 6.25 | 5.42 | 3.42 | 3.11 |
Interest Coverage Ratio (X) | 7.20 | 5.16 | 4.59 | 4.99 | 4.21 |
Interest Coverage Ratio (Post Tax) (X) | 4.86 | 3.52 | 2.64 | 3.02 | 2.44 |
Enterprise Value (Cr.) | 129.99 | 113.80 | 119.96 | 93.74 | 79.60 |
EV / Net Operating Revenue (X) | 0.77 | 0.57 | 0.62 | 0.65 | 0.57 |
EV / EBITDA (X) | 5.70 | 5.20 | 6.30 | 5.36 | 4.41 |
MarketCap / Net Operating Revenue (X) | 0.65 | 0.48 | 0.48 | 0.35 | 0.32 |
Price / BV (X) | 1.04 | 0.95 | 1.03 | 0.60 | 0.56 |
Price / Net Operating Revenue (X) | 0.65 | 0.48 | 0.48 | 0.35 | 0.32 |
EarningsYield | 0.05 | 0.11 | 0.07 | 0.13 | 0.13 |
After reviewing the key financial ratios for Mohini Health & Hygiene Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.21. This value is below the healthy minimum of 5. It has decreased from 5.86 (Mar 24) to 3.21, marking a decrease of 2.65.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.21. This value is below the healthy minimum of 5. It has decreased from 5.86 (Mar 24) to 3.21, marking a decrease of 2.65.
- For Cash EPS (Rs.), as of Mar 25, the value is 5.83. This value is within the healthy range. It has decreased from 8.22 (Mar 24) to 5.83, marking a decrease of 2.39.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 57.76. It has increased from 55.05 (Mar 24) to 57.76, marking an increase of 2.71.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 57.76. It has increased from 55.05 (Mar 24) to 57.76, marking an increase of 2.71.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 92.00. It has decreased from 109.46 (Mar 24) to 92.00, marking a decrease of 17.46.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 12.50. This value is within the healthy range. It has increased from 12.00 (Mar 24) to 12.50, marking an increase of 0.50.
- For PBIT / Share (Rs.), as of Mar 25, the value is 9.88. This value is within the healthy range. It has increased from 9.64 (Mar 24) to 9.88, marking an increase of 0.24.
- For PBT / Share (Rs.), as of Mar 25, the value is 8.15. This value is within the healthy range. It has increased from 7.31 (Mar 24) to 8.15, marking an increase of 0.84.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.21. This value is within the healthy range. It has decreased from 5.86 (Mar 24) to 3.21, marking a decrease of 2.65.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.21. This value is within the healthy range. It has decreased from 5.86 (Mar 24) to 3.21, marking a decrease of 2.65.
- For PBDIT Margin (%), as of Mar 25, the value is 13.58. This value is within the healthy range. It has increased from 10.96 (Mar 24) to 13.58, marking an increase of 2.62.
- For PBIT Margin (%), as of Mar 25, the value is 10.74. This value is within the healthy range. It has increased from 8.80 (Mar 24) to 10.74, marking an increase of 1.94.
- For PBT Margin (%), as of Mar 25, the value is 8.85. This value is below the healthy minimum of 10. It has increased from 6.68 (Mar 24) to 8.85, marking an increase of 2.17.
- For Net Profit Margin (%), as of Mar 25, the value is 3.48. This value is below the healthy minimum of 5. It has decreased from 5.35 (Mar 24) to 3.48, marking a decrease of 1.87.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.48. This value is below the healthy minimum of 8. It has decreased from 5.35 (Mar 24) to 3.48, marking a decrease of 1.87.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.55. This value is below the healthy minimum of 15. It has decreased from 10.64 (Mar 24) to 5.55, marking a decrease of 5.09.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.10. This value is within the healthy range. It has increased from 15.83 (Mar 24) to 16.10, marking an increase of 0.27.
- For Return On Assets (%), as of Mar 25, the value is 3.48. This value is below the healthy minimum of 5. It has decreased from 7.65 (Mar 24) to 3.48, marking a decrease of 4.17.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.05 (Mar 24) to 0.01, marking a decrease of 0.04.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.32. This value is within the healthy range. It has increased from 0.22 (Mar 24) to 0.32, marking an increase of 0.10.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.09. It has decreased from 1.44 (Mar 24) to 1.09, marking a decrease of 0.35.
- For Current Ratio (X), as of Mar 25, the value is 2.08. This value is within the healthy range. It has decreased from 3.19 (Mar 24) to 2.08, marking a decrease of 1.11.
- For Quick Ratio (X), as of Mar 25, the value is 1.42. This value is within the healthy range. It has decreased from 2.41 (Mar 24) to 1.42, marking a decrease of 0.99.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.38. This value is within the healthy range. It has decreased from 6.25 (Mar 24) to 4.38, marking a decrease of 1.87.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 7.20. This value is within the healthy range. It has increased from 5.16 (Mar 24) to 7.20, marking an increase of 2.04.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.86. This value is within the healthy range. It has increased from 3.52 (Mar 24) to 4.86, marking an increase of 1.34.
- For Enterprise Value (Cr.), as of Mar 25, the value is 129.99. It has increased from 113.80 (Mar 24) to 129.99, marking an increase of 16.19.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 24) to 0.77, marking an increase of 0.20.
- For EV / EBITDA (X), as of Mar 25, the value is 5.70. This value is within the healthy range. It has increased from 5.20 (Mar 24) to 5.70, marking an increase of 0.50.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.48 (Mar 24) to 0.65, marking an increase of 0.17.
- For Price / BV (X), as of Mar 25, the value is 1.04. This value is within the healthy range. It has increased from 0.95 (Mar 24) to 1.04, marking an increase of 0.09.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.48 (Mar 24) to 0.65, marking an increase of 0.17.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.11 (Mar 24) to 0.05, marking a decrease of 0.06.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mohini Health & Hygiene Ltd:
- Net Profit Margin: 3.48%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.1% (Industry Average ROCE: 13.22%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.55% (Industry Average ROE: 10.35%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.86
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.42
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 9.06 (Industry average Stock P/E: 24.52)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.32
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.48%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Medical Equipment & Accessories | Plot No 109, Sector 3, Dhar Madhya Pradesh 454774 | cs@mohinihealthandhygiene.com, http://www.mohinihealthandhygiene.com |
Management | |
---|---|
Name | Position Held |
Mr. Avnish Bansal | Managing Director |
Mr. Viral Patel | Executive Director |
Mr. Sarvapriya Bansal | Whole Time Director |
Mrs. Parul Agarwal | Whole Time Director |
Mr. Mukesh Vyas | Ind. Non-Executive Director |
Mr. Chandrashekhar Bobra | Ind. Non-Executive Director |
Mr. Mukul Jain | Ind. Non-Executive Director |
Mr. Mahesh Fogla | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Mohini Health & Hygiene Ltd?
Mohini Health & Hygiene Ltd's intrinsic value (as of 14 October 2025) is 42.73 which is 16.71% lower the current market price of 51.30, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹93.6 Cr. market cap, FY2025-2026 high/low of 86.9/46.0, reserves of ₹87 Cr, and liabilities of 168 Cr.
What is the Market Cap of Mohini Health & Hygiene Ltd?
The Market Cap of Mohini Health & Hygiene Ltd is 93.6 Cr..
What is the current Stock Price of Mohini Health & Hygiene Ltd as on 14 October 2025?
The current stock price of Mohini Health & Hygiene Ltd as on 14 October 2025 is 51.3.
What is the High / Low of Mohini Health & Hygiene Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Mohini Health & Hygiene Ltd stocks is 86.9/46.0.
What is the Stock P/E of Mohini Health & Hygiene Ltd?
The Stock P/E of Mohini Health & Hygiene Ltd is 9.06.
What is the Book Value of Mohini Health & Hygiene Ltd?
The Book Value of Mohini Health & Hygiene Ltd is 57.8.
What is the Dividend Yield of Mohini Health & Hygiene Ltd?
The Dividend Yield of Mohini Health & Hygiene Ltd is 0.00 %.
What is the ROCE of Mohini Health & Hygiene Ltd?
The ROCE of Mohini Health & Hygiene Ltd is 14.1 %.
What is the ROE of Mohini Health & Hygiene Ltd?
The ROE of Mohini Health & Hygiene Ltd is 10.0 %.
What is the Face Value of Mohini Health & Hygiene Ltd?
The Face Value of Mohini Health & Hygiene Ltd is 10.0.